We are delighted to share that the first 4 patients have been enrolled and treated in our FDA approved IDE study. A huge thank you to Dr. Sherzod Iskhakov and his team who performed the procedures.

We are particularly encouraged that a number of our early enrolled patients are direct referrals of participants from our original pilot study. The fact they chose to enroll after seeing first hand the benefits experienced by family and friends is particularly rewarding.

Thanks to our team, our Global Principal Investigator, Dr. Ari Isaacson and all our clinical partners for making this milestone possible. We look forward to welcoming more patients across our participating sites.

To learn more about the trial, visit https://lnkd.in/eUhzg62Q